Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhodiola Crenulata in COPD
NCT02242461Phase 2Completed
- Sponsor
- Chung Shan Medical University
- Start
- May 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Rhodiola Crenulata with Placebo (2 arms). Primary endpoint: Six-Minute Walk Distance at 12 weeks. Started May 2012; status: completed.
02
Drugs
rhodiola crenulata
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02242461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242461.